Relationship between ABO blood group distribution and clinical characteristics in patients with COVID-19
- PMID: 32562665
- PMCID: PMC7832938
- DOI: 10.1016/j.cca.2020.06.026
Relationship between ABO blood group distribution and clinical characteristics in patients with COVID-19
Abstract
Objective: To explore ABO blood group distribution and clinical characteristics in patients with COVID-19.
Methods: The clinical data of 187 patients with COVID-19 seen between January 20, 2020 and March 5, 2020 at the First Hospital of Changsha were retrospectively analyzed. The differences in the ABO blood group distribution between COVID-19 patients and the control group (1991 cases) were analyzed. The relationship between blood type and clinical characteristics was analyzed.
Results: Of the 187 patients with COVID-19, 69 had type A (36.90%), 63 had type B (33.69%), 41 had type O (21.92%), and 14 had type AB blood (7.49%). The proportion of patients with type A blood in the COVID-19 group was significantly higher than that in the control group (36.90% vs. 27.47%, P = 0.006), while the proportion of patients with type O blood in the COVID-19 group was significantly lower than that in the control group (21.92% vs. 30.19%, P = 0.018). The risk of COVID-19 was higher for individuals with blood group A than for those with blood group O (OR = 1.849, 95% CI = 1.228-2.768, P = 0.003). The risk of COVID-19 was higher for patients with blood group A than for those with a blood group other than A (OR = 1.544, 95% CI = 1.122-2.104, P = 0.006). Patients with blood group O had a lower risk of COVID-19 than non-O blood group patients (OR = 0.649, 95% CI = 0.457-0.927, P = 0.018). The ABO blood group distribution was related to COVID-19 status.
Conclusions: Patients with blood group A had an increased risk for infection with SARS-CoV-2, whereas blood group O was associated with a decreased risk, indicating that certain ABO blood groups were correlated with SARS-CoV-2 susceptibility. Blood type was related to some clinical characteristics of patients with COVID-19.
Keywords: ABO blood group; COVID-19; Clinical characteristics.
Copyright © 2020 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare that there is no conflict of interest or financial disclosure related to this publication.
References
-
- Gao J., Tian Z., Yang X. Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Biosci. Trends. 2020;14(1):72–73. - PubMed
-
- Kalayanarooj S., Gibbons R.V., Vaughn D., Green S., Nisalak A., Jarman R.G., Mammen M.P., Jr., Perng G.C. Blood group AB is associated with increased risk for severe dengue disease in secondary infections. J. Infect. Dis. 2007;195(7):1014–1017. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous
